I-PRO InformaPRO
  • HOME
    • About
  • Bioresearch
    • Databases
    • Clinical Trials
    • Statistics
    • Health Economics
    • Health Policies Monitoring >
      • Health Policies Reports
  • R&D
    • Research and Development
    • Web Portals
    • EuResist Network
    • Technological Integration
  • Training
    • CME and academic education
    • Training Web Platforms
    • Distance Education / Remote Training
    • Scientific Workshops
    • Monitors' training
  • Projects
    • LIFE2020: ABILITA2
    • TROCAR
    • MeuSiX
    • KRG-HIS
    • ARCA
    • AMS >
      • ARCA-AMS publications
    • EuResist Project
    • Abilita
    • RARE
    • IKR
    • SecurePhone
    • Webconference
  • Partners
  • Contacts
  • CAREERS
AMS GROUP A
1. Poster: 15th EU Meeting on HIV & Hepatitis - AMS2016A ID: 74
Sara Modica1, Barbara Rossetti1,2, Francesca Lombardi3, Filippo Lagi4, Manuel Maffeo1, Roberto D’autilia5, Monica Pecorari6, Ilaria Vicenti7, Bianca Bruzzone8, Giacomo Magnani9, Stefania Paolucci10, Daniela Francisci11, Giovanni Penco12, Daria Sacchini13, Maurizio Zazzi7, Andrea De Luca1, Antonio Di Biagio14 Sara Modica - "Prevalence of resistance mutations to Integrase Inhibitors in INSTI-experienced HIV-1 infected patients in a large Italian cohort."

2. Oral Communication: ICAR 2017 ­ Di Carlo Domenico, ID Abstract: 81
Sara Modica1, Barbara Rossetti1,2, Francesca Lombardi3, Filippo Lagi4, Manuel Maffeo1, Roberto D’autilia5, Monica Pecorari6, Ilaria Vicenti7, Bianca Bruzzone8, Giacomo Magnani9, Stefania Paolucci10, Daniela Francisci11, Giovanni Penco12, Daria Sacchini13, Maurizio Zazzi7, Andrea De Luca1, Sara Modica - "Prevalence of resistance mutations to Integrase Inhibitors in INSTI-experienced HIV-1 infected patients in a large Italian cohort."

AMS GROUP  B:
1. Poster: Abstract ICAR 2017 Redi David, ID Abstract: 277
D. Redi1, C. Spertilli Raffaelli1, A. D’Avino2, M.C. Postorino3, A. Bezenchek4, R. Scutari5, A. Emiliozzi2, M. Di Gaetano6, S. Barbaliscia5, I. Fanti2, D. Di Carlo5, S. Di Giambenedetto2, V. Borghi6, M. Zazzi7, M.M. Santoro5  Redi David - "Virological Response and Resistance Profile in HIV-1 Infected Patients Starting a First-Line Regimen Containing a Protease Inhibitor or an Integrase Inhibitor in Clinical Practice"

AMS GROUP ​C:
1. Poster: 15th EU Meeting on HIV & Hepatitis, ID Abstract: 51 - D. Di Carlo1, A. Bezenchek2, A. Battisti1, F. Incardona2,3, D.F. Bavaro4, P. Zuccalà5, F. Bai6, E. Salomoni7, S. Giachè7, R. Gagliardini8, S. Di Giambenedetto8, M. Pecorari9, M. Zazzi10, A. De Luca10, S. Lo Caputo4

2. Oral Communication: ICAR 2017 ­ Di Carlo Domenico, ID Abstract: 179
D. Di Carlo1, D.F. Bavaro2, A. Battisti1, S. Giachè3, E. Salomoni3, F. Incardona4,5, P. Zuccalà6, F. Bai7, R. Gagliardini8, S. Di Giambenedetto8, M. Pecorari9, M. Zazzi10, A. De Luca10, A. Bezenchek5, S. Lo Caputo2

3. Poster: Congresso Nazionale SIV-ISV - 25-28 Giugno 2017, Milano - OK 20170612 S. Giachè1, E. Salomoni1, D. Di Carlo2, F. Bai3, D.F. Bavaro4, A. Battisti2, F. Incardona5-10, P. Zuccalà6, R. Gagliardini7, S. Di Giambenedetto7, M. Pecorari8, M. Zazzi9, A. De Luca9, S. Lo Caputo4, A. Bezenchek10 Giachè Susanna: “EFFICACIA DELLO SWITCH TERAPEUTICO A DARUNAVIR/RITONAVIR + LAMIVUDINA O ATAZANAVIR/RITONAVIR + LAMIVUDINA NELLA PRATICA CLINICA IN PAZIENTI VIROLOGICAMENTE SOPPRESSI ARRUOLATI NEL DATABASE ARCA”

InformaPRO S.r.l.             privacy policy

 via Guido Guinizelli, 98 - 00152 ROME  |  Phone +39 065882352  | amministrazione@informa.pro  |  info@informapro.it  |  P.IVA 08095781004